Skip to main content
European Commission logo
Enterprise Europe Network

A company completed development of AI software that can diagnose more diseases than any closest competitor with very high accuracy using explainable AI algorithms is looking for commercial/ technology agreement

Summary

Profile Type
  • Technology request
POD Reference
TRTR20240927004
Term of Validity
1 July 2025 - 1 July 2026
Company's Country
  • Turkey
Type of partnership
  • Research and development cooperation agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A company completed development of AI software that can diagnose more diseases than any closest competitor with very high accuracy using explainable AI algorithms is looking for commercial/ technology agreement
The company looking for collaborators for commercialization, clinical pilots, and potential technology partnerships for future diagnosis projects using Machine Learning.
Full Description
The company, established in 2014, is working on an AI-powered software that accurately diagnoses eye diseases such as Diabetic Retinopathy, Age-Related Macular Degeneration, Glaucoma, and Retinal Vein Occlusion. With over 96% specificity and sensitivity, and six prospective clinical trials EyeCheckup is Europe most validated AI for diagnosing eye diseases. Specifically designed for use without a presence of ophthalmologist EyeCheckup is suitable for mass screening and diagnostic usage at primary care, opticians, and family doctors.

Leading AI health tech company has completed development of AI software that can diagnose more diseases than any closest competitor with very high accuracy using explainable AI algorithms. Articles published in Nature Eye magazine, IEEE Xplore, and more articles pending . The company is looking for collaborators for commercialization, clinical pilots, and potential technology partnerships for future diagnosis projects using Machine Learning.

The company is looking for partners for commercial or non-commercial pilot evaluation of EyeCheckup at university hospitals with a prospect for further commercial usage.

The company seeks investors who are not only interested in funding it’s growth but also share the vision of transforming eye care and diabetes. The expected role of investors includes providing capital to accelerate our expansion, particularly in scaling production, enhancing marketing efforts, and entering new markets, such as the U.S. Investors will also play a strategic role by offering insights, guidance, and connections that can help the company navigate the complexities of global healthcare markets.
Commercialization Partners: The company is looking for commercialization partners who can help expand company’s presence in both B2B and B2C markets
Advantages and Innovations
1. CE MDR certified.
2. Highest specificity and sensitivity
3. Highest number of diseases diagnosed
Technical Specification or Expertise Sought
Investors: The company seeks investors who are not only interested in funding it’s growth but also share the vision of transforming eye care and diabetes. The expected role of investors includes providing capital to accelerate our expansion, particularly in scaling production, enhancing marketing efforts, and entering new markets, such as the U.S. Investors will also play a strategic role by offering insights, guidance, and connections that can help the company navigate the complexities of global healthcare markets.

Commercialization Partners: The company is looking for commercialization partners who can help expand company’s presence in both B2B and B2C markets
Stage of Development
  • Already on the market
Sustainable Development Goals
  • Goal 3: Good Health and Well-being

Partner Sought

Expected Role of a Partner
Investors: The company seeks investors who are not only interested in funding it’s growth but also share the vision of transforming eye care and diabetes. The expected role of investors includes providing capital to accelerate our expansion, particularly in scaling production, enhancing marketing efforts, and entering new markets, such as the U.S. Investors will also play a strategic role by offering insights, guidance, and connections that can help the company navigate the complexities of global healthcare markets.

Commercialization Partners: The company is looking for commercialization partners who can help expand company’s presence in both B2B and B2C markets.
Type and Size of Partner
  • SME 11-49
Type of partnership
  • Research and development cooperation agreement

Dissemination

Technology keywords
  • 01003003 - Artificial Intelligence (AI)
  • 06005004 - Remote diagnostics
  • 01004001 - Applications for Health
  • 06001013 - Medical Technology / Biomedical Engineering
  • 06005003 - Health information management
Market keywords
  • 05007006 - Computer-aided diagnosis and therapy
  • 05004005 - Diagnostic equipment
  • 05002005 - Other medical imaging
  • 02007004 - Program development tools/languages
Targeted countries
  • All countries